Industry News, Mergers and Acquisitions, Suppliers News

Evonik Agrees to Sell Methacrylates Biz to Advent International for €3 Billion

Expected to close in the third quarter of this year.

Author Image

By: Anthony Locicero

Copy editor, New York Post

Evonik signed an agreement to sell its Methacrylates business to Advent International for €3 billion.    The selling price (enterprise value) is 8.5 times the business’ EBITDA.    The transaction is subject to approval by the authorities in several countries and is expected to close in the third quarter of this year. The Methacrylates business has 18 production sites and 3,900 employees worldwide.    From 2016 to 2018, the business generated an average annual EBITDA ...

Continue reading this story and get 24/7 access to Ink World magazine for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Ink World magazine Newsletters